Project Grant R01MH138682

Award Date 12/1/24
Completion Date 11/30/28
Dollars Obligated $434K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $787,584 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of North Carolina at Chapel Hill (UNC-CH) to conduct a longitudinal study on the trajectories of functional brain network organization from birth to early adulthood as predictors of executive function and psychopathology. The study aims to characterize neural and behavioral trajectories of executive function (EF) from infancy to emerging adulthood,...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $738,037 to The Washington University in Missouri to conduct research on predicting the development of attenuated psychotic symptoms (APS) among youth who endorse persistent distressing psychotic-like experiences (PD-PLES). The key objectives of this 4-year research project are to: 1) Examine the prevalence of APS among youth in the...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, awarded a $156,130 Project Grant (CFDA 93.350) to The Ohio State University to elucidate the cerebellar contributions to social cognition across psychiatric disorders. The project aims to develop a brain network model of dynamic interactions between key regions involved in mentalizing, a critical social cognitive function, among a transdiagnostic sample of youth and young adults with...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $830,168 to The Trustees of the University of Pennsylvania to study the role of the cytoskeletal protein βII-spectrin in the cerebellum and its contribution to neurodevelopmental disorders. The research aims to define the molecular mechanisms underlying disruption of excitable axonal domains and synaptic transmission in cerebellar granule cells...
This $1.8 million project grant from the National Institutes of Health's National Institute of Mental Health will fund the development of high-throughput methods for measuring synaptic connectivity at single-cell resolution in the cerebral cortex. Over a three-year period from September 2022 through August 2025, The Broad Institute, Inc. will pursue viral, functional, and molecular approaches to map local cortical circuitry. These include optimizing rabies-based trans-synaptic tracing for...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop a digital platform focused on advancing help-seeking in youth at clinical high risk for developing psychosis. The total funding amount is $2,005,780.00 with an award date of August 1, 2024 and an ultimate completion date of May 31, 2028. The key products and services to be delivered include: Characterizing help-seeking subtypes in...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a research project titled "Mapping the Functional Organization of the Cortex Across Development: The Principal Hierarchy and Transdiagnostic Psychopathology Risk". The $107,948 award, with a period of performance from December 2025 to June 2027, will be conducted by the Trustees of the University of Pennsylvania, doing...
This $784,642 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program will support research at the New York Genome Center, Inc. (Nygc) to leverage electronic health records, dimensional phenotyping, and genomic analysis to develop predictive models for clinical outcomes in psychosis-related disorders. The key objectives are to: 1) Build machine learning models to forecast treatment response, illness severity, medical...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $202,840 to Indiana University to conduct longitudinal research on sensorimotor function and its relationship to psychotic symptoms. The key objectives are to: 1) cross-sectionally identify aberrant subprocesses of motor learning in psychosis and link these to brain structure and symptoms, and 2) longitudinally map the malleability of...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a $121,424 study examining the relationship between early sleep disruption, functional brain networks, and developmental trajectories in infancy. The study will leverage data from two longitudinal NIH-funded projects - the Infant Brain Imaging Study (IBIS) and the Healthy Brain and Child Development (HBCD) Study - to (1) investigate how...

DEVELOPMENT OF CEREBELLAR-CORTICAL FUNCTIONAL CONNECTIVITY IN YOUTH AND ITS PREDICTION OF PSYCHOSIS - ABSTRACT CEREBELLUM DYSFUNCTION IS KNOWN TO BE STRONGLY IMPLICATED IN THE PATHOGENESIS OF PSYCHOSIS. OUR PAST RESEARCH HAS PROVIDED CONVERGING EVIDENCE THAT FUNCTIONAL DYSCONNECTIVITY IN THE CEREBELLAR-CORTICAL CIRCUITRY IS A ROBUST NEURAL ANOMALY THAT IS UBIQUITOUSLY MANIFEST ACROSS DIFFERENT CLINICAL STAGES AND BRAIN STATES IN PSYCHOTIC PATIENTS, PREDICTIVE OF PSYCHOSIS ONSET, AND RELATED TO GENETIC RISK FOR PSYCHOSIS. THEREFORE, CEREBELLAR-CORTICAL DYSCONNECTIVITY IS LIKELY TO REFLECT A PATHOLOGICAL TRAIT ARISING FROM ABNORMAL NEURODEVELOPMENT, EMPHASIZING THE IMPORTANCE OF UNDERSTANDING THE DEVELOPMENTAL TRAJECTORIES OF CEREBELLAR-CORTICAL CONNECTIVITY AND THEIR ASSOCIATIONS WITH PSYCHOSIS. TO THIS END, WE WILL UTILIZE DATA FROM FOUR LARGE NEURODEVELOPMENT DATASETS WITH RESTING-STATE FMRI SCANS AND EXTENSIVE CLINICAL AND COGNITIVE ASSESSMENTS, INCLUDING THE LIFESPAN HUMAN CONNECTOME PROJECT IN DEVELOPMENT (HCP-D), THE PHILADELPHIA NEURODEVELOPMENTAL COHORT (PNC), THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY PHASE 3 (NAPLS-3) AND NAPLS PHASE 2 (NAPLS-2), WITH A TOTAL OF > 3000 INDIVIDUALS FROM 5 TO 21 YEARS OLD. WE WILL USE THE HCP-D DATASET AS THE BENCHMARK TO CHART NORMAL DEVELOPMENT CURVES OF CEREBELLAR-CORTICAL CONNECTIVITY FROM CHILDHOOD TO EARLY ADULTHOOD, AND USE THE PNC DATASET TO COMPREHENSIVELY INVESTIGATE HOW DEVIATIONS FROM THESE NORMATIVE CURVES PREDICT PSYCHOTIC-LIKE SYMPTOMS AND COGNITIVE DISTURBANCES DURING NEURODEVELOPMENT. THE RESULTS WILL BE SUMMARIZED INTO INDIVIDUALIZED "CEREBELLAR RISK SCORES" AND USED FOR PREDICTION OF PSYCHOSIS ONSET IN THE NAPLS-3 AND NAPLS-2 DATASETS. OVERALL, THE OUTCOMES FROM THIS STUDY WILL 1) PROVIDE DETAILED INSIGHTS INTO THE DEVELOPMENTAL PATTERNS OF CEREBELLAR-CORTICAL CONNECTIVITY IN TYPICALLY AND ATYPICALLY DEVELOPED YOUTH; 2) BRIDGE THE GAP BETWEEN SYSTEMS-LEVEL CEREBELLAR DYSFUNCTION AND ITS COGNITIVE AND SYMPTOM CORRELATES DURING NEURODEVELOPMENT; AND 3) GENERATE AN INDIVIDUALIZED, GENERALIZABLE, CEREBELLUM-BASED RISK SCORE THAT CAN BE LEVERAGED FOR FUTURE PSYCHOSIS PREDICTION AND EARLY INTERVENTION STUDIES.

Posted 11/18/24, 12:00 AM